tradingkey.logo

Teva Pharmaceutical Industries Ltd

TEVA
查看詳細走勢圖
34.690USD
-0.110-0.32%
收盤 02/06, 16:00美東報價延遲15分鐘
39.80B總市值
28.17本益比TTM

Teva Pharmaceutical Industries Ltd

34.690
-0.110-0.32%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.32%

5天

+1.79%

1月

+8.03%

6月

+116.68%

今年開始到現在

+11.15%

1年

+100.64%

查看詳細走勢圖

操作建議

Teva Pharmaceutical Industries Ltd當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在藥品行業排名45/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為35.15。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Teva Pharmaceutical Industries Ltd評分

相關信息

行業排名
45 / 159
全市場排名
122 / 4521
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
極度看空

Teva Pharmaceutical Industries Ltd亮點

亮點風險
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值28.17,處於3年歷史高位
機構減倉
最新機構持股666.08M股,環比減少16.96%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉114.00股

分析師目標

基於 13 分析師
買入
評級
35.147
目標均價
+1.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Teva Pharmaceutical Industries Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Teva Pharmaceutical Industries Ltd簡介

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
公司代碼TEVA
公司Teva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
網址https://www.tevapharm.com/
KeyAI